Ann: Second Supplementary Scheme Booklet, page-58

The second supplementary scheme booklet goes a long way to clarify many of the issues. It is a pity that TWO supplementary booklets were required. The board is at last on record as stating that ResApp is viable without Pfizer. I have learned far more from reading the Court decisions than I have from information provided by the BOD. I am looking forward to studying the decisions of 23 Aug and 25 Aug, when published, and to which I will provide links on the appropriate thread.